Minsal: The periodicity of the bivalent vaccine “will be evaluated on merit; for the moment, it remains annual”

Minsal: The periodicity of the bivalent vaccine "will be evaluated on merit; for the moment, it remains annual"

The head of epidemiology of the Minsal, christian garciashowed up this friday what’s left of the day of Cooperative that any modification of the frequency of application of the bivalent vaccine against Covid-19 – currently annual – will be assessed “on merit”.

The dose contains both the original Wuhan strain and the omicron variant, providing better protection against the currently circulating virus.

“Of course, this is subject to constant evaluation. It will be evaluated on merit, according to the global scenario, according to the opinion of the expert committees, the vaccine advisory committee, the frequency. For now, we’re going to keep it annual.”Garcia said.

So far, people who can receive the bivalent vaccine are only healthcare personnel, people over 60, immunocompromised people and the chronically ill.

“For now, these vaccines only target the groups most at risk. Because? Because until the second reinforcement, what has been demonstrated is that after several months there is still good protection vis-à-vis serious cases and deaths”, defended the head of the epidemiology.

Ce matin, le ministère de la Santé a signalé qu’avec une date limite d’hier, jeudi, ils ont administré 1 124 027 doses du vaccin annuel contre le Covid-19correspond à 19,61 % couverture de la population cible estimée à 5 732 092 personnes.

Sur les doses totales administrées, 201 013 sont des agents de santé (couverture de 44,54 %), 59 147 personnes atteintes de maladies chroniques (couverture de 3,52 %) et 863 867 personnes âgées (couverture de 24,01 %).

Concernant les schémas de primo-vaccination contre le SRAS-CoV-2, qui considèrent une population cible de 15 200 840 personnes âgées de 18 ans et plus, 94,29 % (14 332 757) ont terminé leur schéma vaccinal.

#Minsal #periodicity #bivalent #vaccine #evaluated #merit #moment #remains #annual

Leave a Comment

Your email address will not be published.